Itamar Medical EBIT

Itamar Medical (ITMMF) currently reports a EBIT of $-17M as of September 2021. That compares with $-3.5M in the prior-year period — down 390.7% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Itamar Medical's EBIT history and peer comparisons.

Itamar Medical's EBIT decreased from $-3.5M to $-17M — a 390.7% year-over-year decrease (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Itamar Medical's EBIT of $-17M is lower than the Healthcare sector average of $23B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Itamar Medical reported $-17M in EBIT as of September 2021. That compares with $-3.5M in the prior-year period — down 390.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-17M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Itamar Medical, and consider following ITMMF for alerts when major investors trade the stock.